<?xml version="1.0" encoding="UTF-8"?>
<p id="d1e253">Similarly, unprecedented efforts to develop vaccines 
 <xref rid="b4" ref-type="bibr">[4]</xref> or monoclonal antibodies (e.g., 
 <xref rid="b5" ref-type="bibr">[5]</xref>) against SARS-CoV-2 also are underway. Should any prove safe and effective, they may reduce infectiousness as well as susceptibility to infection.
</p>
